P863 KEYNOTE-022 parts 4 and 5: pembrolizumab plus...

Journal for ImmunoTherapy of Cancer 2020 / 04 Vol. 8; Iss. Suppl 1

P863 KEYNOTE-022 parts 4 and 5: pembrolizumab plus trametinib for patients with solid tumors or BRAF wild-type melanoma

Maio, Michele, Carlino, Matteo, Joshua, Anthony, McWhirter, Elaine, Ribas, Antoni, Ascierto, Paolo, Miller, Wilson, Butler, Marcus, Ferrucci, Pier, Zielinski, Robert, Vecchio, Michele Del, Gasal, Edua
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
8
Journal:
Journal for ImmunoTherapy of Cancer
DOI:
10.1136/lba2019.16
Date:
April, 2020
File:
PDF, 478 KB
2020
Conversion to is in progress
Conversion to is failed